Hybrid Classes
We provide offline, online and recorded lectures in the same amount.
Personalised Mentoring
Every aspirant is unique and the mentoring is customised according to the strengths and weaknesses of the aspirant
Topicwise Mindmaps
In every Lecture. Director Sir will provide conceptual understanding with around 800 Mindmaps.
Quality Content
We provide you the best and Comprehensive content which comes directly or indirectly in UPSC Exam.
Context: Scientists of Indian Institute of Technology (IIT), Jodhpur have explored the neuroinvasive nature of the COVID 19 virus SARS-CoV-2 highlighting that loss of smell and taste of infected patients makes their entire Central Nervous System (CNS) and the underlying structures in the brain more prone to viral infection with devastating effects. The paper recounts a recently conducted study on the brain scans (CT and MRI) of a patient infected by COVID-19 virus that shows a rare encep
How to tackle the new strain of COVID? Constant monitoring is the only way India can build up its defences against new virus strains In less than a month, it will be a year since India confirmed its first SARS-CoV-2 cases in Kerala. From then and now, India looks infinitely more prepared in terms of testing capacity, vaccine candidates in development, public awareness and the kaleidoscopic experiences of those who have been exposed to the virus. However, the report of the new varia
Covishield and COVID Vaccine Covishield, the vaccine candidate from the Pune-based Serum Institute of India, was approved by a subject expert committee (SEC) of the Drugs Controller General of India (DCGI). The SEC gives its recommendation to the DCGI which is the approving authority for drugs and vaccines. Similar to that in the United Kingdom, we’ve approved the vaccine to be given in two doses 4-12 weeks apart. #joinourtelegram# Covishield, which is similar to t
Covishield and Covaxin approved for emergency use as COVID vaccines The Central Drugs and Standards Committee (CDSCO) formally approved the COVID-19 vaccines by Bharat Biotech and the Serum Institute of India (SII). This allows the vaccines — Covishield by SII and based on the Oxford AstraZeneca vaccine, and Covaxin by Bharat Biotech — to be offered to healthcare workers and frontline workers in India. The Health Ministry had said that 3 crore such personnel, considere
Emergency in Malaysia due to COVID-19 Malaysia’s king declared a nationwide state of emergency on Tuesday to fight a coronavirus surge and Parliament was suspended, with critics charging that it was a bid by the unstable government to cling to power. The surprise move came a day after the Prime Minister announced sweeping new curbs across much of the Southeast Asian nation, including the closure of most businesses, and warned the health system was “at breaking point”.
SOP for COVID Vaccination The Union Ministry of Health and Family Welfare (Immunisation Division) has issued a Standard Operating Procedure for the Ministry of Home Affairs in case of Adverse Events Following Immunisation (AEFI). The vaccination drive will start from January 16. The Hindu has a copy of SOP that provides a step by step guide to the police and other response agencies. The SOP is meant to help the investigator ensure appropriate handling of the vaccine, victim assistanc
What is Co-WIN? In good measure, the dry runs were not only a step to test the operational feasibility of various States to roll out the vaccine programme effectively, but also a recce to see if the electronic vaccine intelligence network, eVIN, used during routine immunisation programmes, and remodelled as Co-WIN, was functional at the field-level. Co-WIN aspires to be a comprehensive digital database of every COVID-19 vaccine that will be administered in India — tracking benefici
India sends COVID-19 vaccines to 6 countries: Vaccine diplomacy and SAARC India on Wednesday began the delivery of COVID-19 vaccines to six “neighbouring and key partner countries”. They are Maldives, Bhutan, Bangladesh, Nepal, Myanmar and Seychelles. The delivery began with two special flights carrying the first consignments of Covishield to the Maldives and Bhutan. Sources said Bangladesh and Nepal will receive two large consignments of the same vaccine on Thursda
CoWIN software enhanced for vaccine rollout An enhancement in Co-WIN software has been introduced to cater to the creation of more session sites, more sessions per site, and a change in site location, which is now allowed. “The enhanced version also allows planning and scheduling the sessions for entire week and works for the enhanced safety of the beneficiaries, tagging of contraindications. These new features are being enabled in vaccinator module,. Health Minister Harsh Vardh
World’s largest vaccination programme Prime Minister Narendra Modi will flag off the first phase of the nationwide COVID-19 vaccination drive. The world’s largest vaccination programme will begin at a total of 3,006 session sites across all the States and the Union Territories, which will be connected virtually throughout the exercise. Nearly 100 beneficiaries will receive the vaccine at each of the session sites on Saturday. #joinourtelegram# A dedicated 24x7
COVID-19 vaccines and possible side effects Two COVID-19 vaccines, Covaxin and Covishield, after being granted emergency use authorisation, were rolled out on January 16 across India to inoculate three crore healthcare and frontline workers in the first phase of the vaccination drive. Both the vaccines have been manufactured in India. While Covaxin is produced under a collaboration between Bharat Biotech and the Indian Council of Medical Research, Covishield has been developed by Ast
Nasal SARS-CoV-2 vaccine What is a nasal vaccine? An intranasal vaccine does exactly what it says it does — deliver a vaccine through a spritz through the nostrils. The advantages of this method of vaccine delivery over the injection and oral forms are quite apparent. The method comes with the guarantee of better compliance and the advantage of lower costs. But only clinical trials can determine whether such a vaccine with an easy delivery mechanism can be efficacio
Vaccines are safe for those who are on blood thinners: ICMR Both COVID-19 vaccines approved for emergency use in India — Covaxin and Covishield — are safe for people on blood thinners, Indian Council of Medical Research (ICMR) Director-General Balram Bhargav said on Thursday. At a Health Ministry press conference, he said manufacturers of both the vaccines had approached the Drugs Controller-General of India (DCGI) for revision of this contraindication on their fact sheets.
COVID-19 “performance index” New Zealand and Vietnam were ranked the best performing countries in their response to the pandemic, according to a COVID-19 “performance index” put together by the Lowy Institute, an Australian think tank, which sought to assess the impact of geography, political systems and economic development in assessing outcomes. The index, which was based on six different indicators, including confirmed cases and deaths per million people and th
Inequality Virus Report: Oxfam Indian billionaires increased their wealth by 35% to ?3 trillion during the lockdown, ranking them behind their counterparts in U.S., China, Germany, Russia and France, says the “Inequality Virus Report” brought out by Oxfam, a non-profit organisation. The rise in fortunes of the top 100 billionaires is enough to give every one of the 138 million poorest Indian people a cheque for ?94,045, the report released on the opening day of the World Eco
Novavax American company Novavax, whose COVID-19 vaccine is set to be made in large numbers by the Pune-based Serum Institute of India (SII), has reported that its vaccine has proved to have 89% efficacy in preventing the infection in some trial volunteers in the United Kingdom. However, the efficacy dropped to 60% when it was tested in volunteers in South Africa, a likely consequence of a mutant coronavirus variant that is now deep-rooted there. Since December, scientists have raised
Serological survey of ICMR Context The results of the ICMR’s third serological survey to ascertain the spread of COVID-19 show that nearly one in five Indians — about 270 million — may have been infected. Serological Survey A serological survey is conducted to assess the prevalence of a disease in a population. It is done by detecting the presence of specific antibodies that are produced against the virus.
02 April, 2020
COVID 19
12 Apr,2021
UPSC Class Room Courses
Copyright© Aspire IAS Academy. All rights reserved. Powered by CLT Technologies & Edu-Publishers Private Limited.
24 × 7 Support : 8287714422
Whatsapp : 9999801394
Email Us To : a.kumar.aias@gmail.com
